BHOC has added a source record for Biopure Corp., John T. Gourville's Harvard Business School case published on 29 May 1998.
The case examines a practical decision: launch Oxyglobin for veterinary use, or wait while Hemopure was still being developed for human use? One concern was whether the veterinary product's price would shape expectations for the later human product.
This adds the commercial side of oxygen-carrier development to our historical archive: launch timing, pricing and decisions made before the outcome of human development was known.
Our historical source record includes the case details, the official publisher link and related Biopure documents. It links the 1998 teaching case with the later company reports without treating them as the same type of evidence.